dragon
Scopus Index (2025)

Medical journal of wuhan university

Medical journal of wuhan university (ISSN:1671-8852) is a monthly peer-reviewed scopus-indexed journal from 2001 to present. The publisher of this journal is Science China Press. Medical journal of wuhan university committed to gathering and disseminating excellent research achievements. The journal welcomes all types of General Medicine journal includes Medicine,Pharmacy, Bio-Chemistry, Psychology,Public Health Etc.

Medical journal of wuhan university

Submission Deadline

  • ( Vol 46 , Issue 10 ) | 04 Dec 2025

    Day
    Hour
    Min
    Sec

Publication Date

  • ( Vol 46 , Issue 09 ) | 30 Nov 2025

Aim And Scope

Medical journal of wuhan university

General Medicine, Pharmacy, Bio-Chemistry, Psychology Sciences and Public health:

Anatomy, Physiology, Biochemistry, Pharmacology, Pathology, Forensic medicine, Microbiology, Community Medicine, Otorhinolaryngology, Internal Medicine, General Surgery, Obstetrics and Gynecology, Radiology, Pulmonary Medicine, Dermatology and Venereal diseases, Infectious Diseases, Anaesthesia, Cancer research, Neurosurgery, Orthopedics, Gastroenterology, Neurology, Nephrology, Medical education, Orthopaedics, Paediatrics, Reproduction, Cardiology, Diabetes, Surgery, Nursing, Otolaryngology, Dental, Psychology, Anesthesiology, Dermatology,
Endocrinology, Hepatology, Urology, Venereology, Psychiatry, Biotechnology, Pharmacy, ENT, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutics, Pulmonology, Pharmacognosy, Pharmaceutical, Phatmaceutical Technology, Biopharmaceutics, Pharmacokinetics Pharmacodynamics, Industrial Pharmacy, Drug Design, Quality Assurance, Drug Regulatory Affairs, Phytochemistry, Drug Delivery Systems, Pharmaceutical Nanotechnology, Pharmaceutical Microbiology, Hospital Pharmacy, Clinical Pharmacy, Pharmacy Practice, Drug Discovery, Drug Metabolism, Toxicology, Clinical Research, Pharmacogenomics, Phrmacoinformatics, Pharmacovigilance, Life Sciences like Chemistry,
Biomedical Sciences, Microbiology, Immunology, Forensic, Epidemiology, Oncology, Biomedicine, Dentistry, Physiotherapy, Gynaecology, Dermatoepidemiology, Neuroscience, Ophthalmology, Sexology, Osteology, Kinesiology, Angiology/Vascular Medicine, Critical care Medicine, Haematology, Infectious Diseases and Vaccinology, Bariatrics, Pharmacy and Nursing, Pharmacognosy and Phytochemistry, Radiobiology, Clinical immunology, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Healthcare Services, Healthcare Management, Bioinformatics and Biotechnology, Geriatric Medicine,

Latest Paper Here

Medical journal of wuhan university
ALA-PDT treatment for anal condyloma acuminatum complicated with AIDS: Two cases report and literature review

Highly antiretroviral therapy (HAART) used in Human Immunodeficiency Virus (HIV) treatment may prolong the life span of people living with HIV/Acquired Immune Deficiency Syndrome (AIDS) but may also induce the onset of autoimmune disorders. However, HIV-associated systemic sclerosis (SSc) is an extremely rare occurrence, and only four case reports and two studies documenting this association have been reported to date. We report a rare case of HIV-associated SSc who was referred to us for pain management in her mandibular teeth. A 44-year-old female patient diagnosed with HIV-associated SSc

Manifestations in alopecia areata and androgenetic alopecia as visualized by high-frequency ultrasound

Hair-loss diseases comprise heterogenous conditions with respective pathophysiology and clinicopathological characteristics. Major breakthroughs in hair follicle biology and immunology have led to the elucidation of etiopathogenesis of non-scarring alopecia (e.g., alopecia areata, AA) and cicatricial alopecia (e.g., lichen planopilaris, LPP). High-throughput genetic analyses revealed molecular mechanism underlying the disease susceptibility of hair loss conditions, such as androgenetic alopecia (AGA) and female pattern hair loss (FPHL). Hair loss attracted public interest during the COVID-1

Progress in the application of microneedles in the treatment of melasma

Microneedling, also known as percutaneous collagen induction, using microneedling devices and fabricated microneedle patches, has been widely employed in cosmetic applications for acne scar treatment, skin care, hair loss, melasma, skin rejuvenation, and skin cancer. The micro-channels formed by microneedling through the stratum corneum facilitate the delivery of cosmetic agents and stimulate collagen and elastin production by inducing the wound-healing cascade, keeping the skin shiny and wrinkle-free. Several cosmetic agents, such as ascorbic acid, hyaluronic acid, retinoids, niacinamide,

Effect of different topical methods of tranexamic acid in improving melasma

Tranexamic acid (TXA) has anti-plasmin activity and has been shown when administered orally to be effective against melasma, for which it is considered first-line pharmacotherapy. Several studies have shown that topically applied TXA is also effective against melasma and skin hyperpigmentation caused by sunburn and inflammation. The TXA concentration in the epidermis and dermis/vasculature has been estimated from its distribution in the skin after closed application, and topically applied TXA has thus been shown to act on neutrophils and mast cells in the dermis and on the vascular system.

Research progress of the role of laser on facial skin rejuvenation

For nearly 15 years, carbon dioxide (CO2) laser has been the gold standard in skin rejuvenation. Aim: The purpose of this study was to assess the efficacy of a new laser device which combines CO2 and 1540 nm wavelengths in wrinkles reduction, using a recently developed scanning unit named the µScan DOT scanner. A total of 20 female patients underwent from two to four laser treatment sessions performed once every 45–90 days. Wrinkles reduction was evaluated using the Fitzpatrick Wrinkle Classification System (FWCS). Evaluations of five-point Global Patient’s Assessment (PGA

MJWU